Skip to main navigation Skip to search Skip to main content

New Data from Semaglutide Trials Provides Critical Insights to Guide Next Generation of Therapies Targeting Alzheimer's Pathobiology

Press/Media

Period4 Dec 2025

Media coverage

1

Media coverage